| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.578 | 17.991 | 21.499 | 17.953 | 18.187 | 12.018 | 14.613 | 18.774 | 27.736 | 32.695 |
| Total Income - EUR | 15.533 | 18.045 | 35.492 | 18.081 | 18.334 | 12.139 | 14.665 | 19.086 | 27.736 | 33.110 |
| Total Expenses - EUR | 7.079 | 7.001 | 10.488 | 9.428 | 9.098 | 9.290 | 8.060 | 8.821 | 10.018 | 14.588 |
| Gross Profit/Loss - EUR | 8.454 | 11.043 | 25.004 | 8.654 | 9.236 | 2.849 | 6.605 | 10.265 | 17.718 | 18.522 |
| Net Profit/Loss - EUR | 7.988 | 10.502 | 23.939 | 8.112 | 8.686 | 2.512 | 6.200 | 9.704 | 14.592 | 17.528 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Endomed Consult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.945 | 27.239 | 52.402 | 46.180 | 40.810 | 34.379 | 40.082 | 4.688 | 12.210 | 12.525 |
| Current Assets | 53.998 | 8.792 | 6.650 | 14.163 | 16.316 | 13.675 | 13.216 | 9.479 | 6.529 | 15.400 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 892 | 1.311 | 954 | 1.859 | 1.297 | 602 | 954 | 1.536 | 4.232 | 1.939 |
| Cash | 10.362 | 7.481 | 5.696 | 12.304 | 15.019 | 13.073 | 12.262 | 7.944 | 2.297 | 13.461 |
| Shareholders Funds | 65.632 | 35.617 | 58.954 | 59.197 | 55.645 | 48.114 | 53.248 | 14.023 | 17.585 | 23.784 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 382 | 414 | 535 | 1.554 | 1.902 | 329 | 447 | 712 | 1.742 | 4.760 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endomed Consult Srl